Is it Possible to Estimate the Bioequivalence between Parenteral and Enteral Formulations of Escin?

Escin edema enteral formulation parenteral formulation vascular

Journal

Current reviews in clinical and experimental pharmacology
ISSN: 2772-4336
Titre abrégé: Curr Rev Clin Exp Pharmacol
Pays: Netherlands
ID NLM: 9918227368306676

Informations de publication

Date de publication:
2022
Historique:
received: 24 12 2020
revised: 24 12 2020
accepted: 28 12 2020
pubmed: 11 3 2021
medline: 5 4 2022
entrez: 10 3 2021
Statut: ppublish

Résumé

We suggest that enteral formulation of escin could be used instead of enteral formulation if it is not available.

Identifiants

pubmed: 33687899
pii: CCP-EPUB-114787
doi: 10.2174/1574884716666210309103109
doi:

Substances chimiques

Escin 6805-41-0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

82-84

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Luca Gallelli (L)

Department of Health Science, School of Medicine, University Magna Graecia of Catanzaro, Operative Unit of Clinical Pharmacology, Mater Domini University Hospital, Catanzaro, Italy.
Research Center FAS@UMG, University Magna Graecia of Catanzaro, Italy.

Erika Cione (E)

Department of Pharmacy, Health and Nutritional Sciences, Department of Excellence 2018-2022, University of Calabria, 87036 Rende (CS), Italy.

Leiming Zhang (L)

Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai, 264005, China.

Tian Wang (T)

Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai, 264005, China.

Articles similaires

Humans Enterocolitis, Necrotizing Infant, Newborn Male Female
Humans Female Male Adult Antibodies, Monoclonal, Humanized

Classifications MeSH